Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Oruka Therapeutics announced robust Phase 1 and Phase 2 trial data for its novel biologics ORKA-001 and ORKA-002 targeting chronic skin diseases, particularly plaque psoriasis. ORKA-001 demonstrated high rates of complete skin clearance with a potential for annual dosing. The company raised $700 million in a public offering, extending its cash runw…
PDF Solutions, Inc., a provider of data solutions for the semiconductor and electronics industry, announced an underwritten public offering of 3,806,924 shares of its common stock, including shares sold by a selling stockholder and the company itself. The offering includes an underwriter option to purchase additional shares and is subject to market…
Allogene Therapeutics reported encouraging interim results from its Phase 2 ALPHA3 trial evaluating cemacabtagene ansegedleucel (cema-cel) in first-line Large B-cell Lymphoma (LBCL). The analysis showed significantly higher minimal residual disease (MRD) clearance in the cema-cel arm versus observation (58.3% vs 16.7%) with no treatment-related ser…
Hewlett Packard Enterprise shares jumped sharply after reports that several activist investors, among them Irenic Capital, have accumulated stakes and engaged management. The development compounds pressure from Elliott Management, while solid fiscal results and a constructive technology market backdrop helped lift the stock to a fresh 52-week high.
Ford Motor Company shares jumped 13.18% in afternoon trading after a Morgan Stanley research note highlighted Ford Energy, the automaker's newly formed energy storage subsidiary, as a material and overlooked profit opportunity. The analyst emphasized Ford’s licensing agreement with CATL and suggested imminent supply deals with large commercial cust…
vTv Therapeutics reported Q1 2026 financials showing a $24.1 million net income driven by a $20 million upfront payment from a license agreement amendment with Newsoara Biopharma. The company is on track to complete enrollment in its Phase 3 CATT1 trial for cadisegliatin, a novel oral adjunctive therapy for type 1 diabetes, by Q3 2026, and believes…
Equillium reported Q1 2026 results showcasing progress on its investigational drug EQ504, an aryl hydrocarbon receptor modulator targeting inflammatory diseases. The company plans a Phase 1 study initiation in mid-2026 with data expected about six months later. A strategic leadership appointment and a recent $35 million financing bolster developmen…
Usio, Inc. announced its first quarter 2026 financial results, highlighting a 16% revenue increase to $25.5 million, surpassing consensus estimates by 9%. The company achieved record quarterly revenue, processing volume, and transactions, with total payment dollars processed rising 28% year-over-year. Adjusted EBITDA rose 12% to $0.8 million, and n…
Journey Medical Corporation announced its Q1 2026 financial results showing a 21% year-over-year increase in total revenues to $16.0 million driven by Emrosi® sales reaching $6.3 million. The company reported a narrower net loss of $2.2 million compared to $4.1 million in the prior year quarter and positive adjusted EBITDA of $0.6 million. Cash res…
aTyr Pharma, a clinical stage biotechnology company focused on developing novel therapies derived from its proprietary tRNA synthetase platform, will participate in two investor conferences in New York in May and June 2026. The company will hold investor meetings and a fireside chat featuring CEO Sanjay S. Shukla, with webcasts and replays availabl…
Capital Southwest Corporation reported financial results for the fourth quarter and fiscal year ended March 31, 2026. The company achieved a 17% growth in total investment portfolio to $2.1 billion and a 13.5% increase in investment income over the prior year. Despite a slight decrease in NAV per share to $16.69, Capital Southwest maintained stable…
Grocery Outlet Holding Corp. announced first quarter fiscal 2026 financial results showing a 3.6% increase in net sales to $1.17 billion driven by new store openings. However, comparable store sales declined by 1.0% and the company recorded a net loss of $180.3 million largely due to a $158 million non-cash goodwill impairment and restructuring cha…
MacroGenics reported strong Q1 2026 financial results highlighted by strategic divestiture of manufacturing operations to Bora Pharmaceuticals and expanded monetization of ZYNYZ royalties, expected to generate up to $202.5 million in proceeds. The company is focusing on its core antibody-based oncology pipeline with multiple upcoming data readouts …
Aquestive Therapeutics reported strong first quarter 2026 results with a 66% revenue increase driven by license, royalty, and manufacturing sales. The company reaffirmed plans to resubmit the NDA for Anaphylm, a non-invasive epinephrine sublingual film, to the FDA in Q3 2026 following successful alignment on study designs. Positive clinical data fo…
Presurance Holdings, Inc. announced its financial results for Q1 2026, showing a notable increase in net income to $2.6 million from $522,000 in the previous year. The company has made strategic progress by exiting less profitable commercial lines and focusing on personal lines homeowners business, resulting in a lower combined ratio and improved u…
Belite Bio, a clinical-stage biopharmaceutical company focused on therapies for degenerative retinal diseases, will host a webcast on May 20, 2026, to discuss its financial results for Q1 2026 and provide a business update. The company is advancing its lead candidate, tinlarebant, with ongoing clinical trials targeting Stargardt disease type 1 and …
Mdxhealth SA reported its Q1 2026 financial results, highlighting a 13% increase in revenue to $27.4 million and a strategic discontinuation of its Resolve UTI testing business due to reimbursement challenges. The company is refocusing on its core prostate cancer diagnostics business, projecting 20-26% revenue growth in 2026 excluding Resolve. Inco…
Fiserv, a global leader in payments and financial technology, has entered into an agreement with private equity specialist Bridgeport Partners to create a joint venture that will consolidate and grow Fiserv's ATM Managed Services, Cash & Logistics, and MoneyPass businesses. The move aims to leverage Bridgeport's operational expertise and investment…
Wrap Technologies, Inc. reported a 45% increase in Q1 2026 revenue to $1.1 million, driven by a 186% rise in product sales and $3.2 million in bookings, including a purchase order from the U.S. Department of Homeland Security. The company is expanding international drone and counter-drone pre-orders and advancing R&D including next-generation multi…
Longer-maturity U.S. Treasury yields climbed to levels not seen since mid-2025 after producer prices for April rose more than expected and several Federal Reserve officials signaled the possibility of further rate increases. The move followed a separate consumer price release showing the fastest annual inflation acceleration in three years, and com…
Bonnie J. Fetch, who serves as the Executive Vice President and President of Operations at CUMMINS INC (NASDAQ:CMI), has completed a transaction involving the sale of common stock. The disposition occurred on May 11, 2026, following a transfer of interests within the company's 401(k) plan. This movement of assets represents a shift in how Fetch man…
Intel has been pulled sharply higher by a sector-wide AI and tech rally. Fundamentals still lag the market’s enthusiasm: negative EPS, negative free cash flow, and stretched multiples vs. underlying profits. Technicals show overbought conditions and heavy options-driven flow. This idea outlines a mid-term short (45 trading days) with an exact entry…
A recent regulatory filing from the Securities and Exchange Commission reveals that Samuel Vicari, serving as the Chief Customer Officer for GLOBALFOUNDRIES Inc. (NASDAQ:GFS), has completed a sale of his remaining equity in the company. The transaction involved the sale of 8,692 ordinary shares on May 11, 2026, effectively bringing Mr. Vicari's dir…
Sylebra Capital LLC, a significant stakeholder in PureCycle Technologies, Inc., has reported the acquisition of restricted stock units (RSUs). This transaction occurs against a backdrop of recent price appreciation for PureCycle Technologies (NASDAQ: PCT), even as the company navigates mixed quarterly financial results and high valuation metrics.
A court exhibit revealed that OpenAI CEO Sam Altman owns more than $2 billion of equity in companies that have existing commercial arrangements with OpenAI. The disclosure was introduced during hearings in Elon Musk's lawsuit seeking $150 billion in damages and Altman's removal from OpenAI leadership, and comes as multiple state attorneys general p…
